Fractyl Health Announces Second Quarter 2025 Financial Results and Business Updates
Provided By GlobeNewswire
Last update: Aug 12, 2025
Randomized 3-month REMAIN-1 Midpoint Cohort data expected in September 2025
Positive 3-month REVEAL-1 Cohort data showed single Revita® procedure sustained weight loss after GLP-1 discontinuation; incremental 6-month open-label data expected in Q4 2025
Read more at globenewswire.com
